SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

LUNGHI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.268
AS - Asia 2.707
EU - Europa 1.736
SA - Sud America 469
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 11.234
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.147
SG - Singapore 1.110
CN - Cina 794
BR - Brasile 385
DE - Germania 351
UA - Ucraina 323
IT - Italia 297
HK - Hong Kong 285
GB - Regno Unito 198
TR - Turchia 175
VN - Vietnam 141
FI - Finlandia 98
PL - Polonia 94
SE - Svezia 88
RU - Federazione Russa 73
CA - Canada 59
MX - Messico 50
ID - Indonesia 49
NL - Olanda 44
FR - Francia 39
IN - India 37
BE - Belgio 34
AR - Argentina 33
JP - Giappone 27
ZA - Sudafrica 23
BD - Bangladesh 19
CZ - Repubblica Ceca 18
EC - Ecuador 18
ES - Italia 14
AT - Austria 12
LT - Lituania 11
IQ - Iraq 10
CO - Colombia 9
CH - Svizzera 8
GR - Grecia 8
IR - Iran 7
JO - Giordania 7
PK - Pakistan 7
PY - Paraguay 7
MA - Marocco 6
MY - Malesia 5
UY - Uruguay 5
VE - Venezuela 5
AL - Albania 4
PH - Filippine 4
PT - Portogallo 4
RO - Romania 4
TN - Tunisia 4
TW - Taiwan 4
AU - Australia 3
CL - Cile 3
DZ - Algeria 3
IL - Israele 3
JM - Giamaica 3
KE - Kenya 3
KW - Kuwait 3
PE - Perù 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EG - Egitto 2
EU - Europa 2
IE - Irlanda 2
LB - Libano 2
NO - Norvegia 2
NP - Nepal 2
PR - Porto Rico 2
SA - Arabia Saudita 2
TH - Thailandia 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
GD - Grenada 1
GH - Ghana 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
KR - Corea 1
KZ - Kazakistan 1
MK - Macedonia 1
NA - Namibia 1
NI - Nicaragua 1
OM - Oman 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
TT - Trinidad e Tobago 1
Totale 11.234
Salva come PNG Salva come JPEG
Città #
Singapore 641
Woodbridge 595
Fairfield 594
Ashburn 554
Houston 391
Chandler 369
Jacksonville 344
Santa Clara 321
Hong Kong 285
Beijing 270
Seattle 262
Ann Arbor 239
New York 213
Wilmington 211
Dallas 208
Cambridge 194
Ferrara 102
Izmir 102
Munich 100
Nanjing 99
Boardman 93
Warsaw 91
Princeton 84
Los Angeles 78
San Diego 59
The Dalles 59
Ho Chi Minh City 47
Milan 47
São Paulo 39
Shanghai 38
Dearborn 37
Jakarta 37
Shenyang 36
Brussels 33
Mexico City 32
Bremen 31
Hefei 30
London 30
Chicago 29
Hanoi 28
Buffalo 26
Tianjin 25
Tokyo 25
Hebei 24
Turku 22
Orem 21
Brooklyn 20
Jiaxing 20
Nanchang 19
Redwood City 18
Phoenix 17
Changsha 16
Nuremberg 16
Frankfurt am Main 15
Johannesburg 15
Toronto 15
Brno 13
Denver 13
Kunming 13
Mountain View 13
Stockholm 13
Auburn Hills 12
Des Moines 12
Düsseldorf 12
Helsinki 12
Mcallen 12
Norwalk 12
Rome 12
San Francisco 12
Dong Ket 11
Falkenstein 11
Montreal 11
Moscow 11
Amsterdam 10
Belo Horizonte 10
Chennai 10
Curitiba 10
Hangzhou 10
Manchester 9
Ottawa 9
Poplar 9
Redmond 9
Atlanta 8
Charlotte 8
Jinan 8
Montréal 8
San Mateo 8
Thái Bình 8
Boston 7
Redondo Beach 7
Vienna 7
Zhengzhou 7
Abdullah 6
Amman 6
Ankara 6
Brasília 6
Florence 6
Fortaleza 6
Mumbai 6
Querétaro 6
Totale 7.781
Salva come PNG Salva come JPEG
Nome #
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 286
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 246
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 240
A highly polymorphic microsatellite in the factor V gene is an informative tool for the study of factor V-related disorders 223
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 223
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 218
Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family 215
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 204
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease 204
A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype 202
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 200
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 195
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 187
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 184
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 183
A missense mutation (Y1702C) in the coagulation factor V gene is a frequent cause of factor V deficiency in the italian population 175
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 173
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 171
A new factor V gene polymorphism (His 1254 Arg) present in subjects of African origin mimics the R2 polymorphism (His 1299 Arg) 171
The factor V Glu1608Lys mutation is recurrent in familial thrombophilia 171
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis 165
Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma 163
Performance prediction models based on anthropometric, genetic and psychological traits of Croatian sprinters 161
A novel factor V null mutation detected in a thrombophilic patient with pseudo-homozygous APC resistance and in an asymptomatic unrelated subject 159
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 158
An underestimated combination of opposites resulting in enhanced thrombotic tendency 156
Interaction of occupational posture, lifestyle and genetic components of thrombophilia 156
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 155
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 152
The factor VIII D I24I E polymorphism is associated with decreased factor VIII activity and not with activated protein C resistance levels 149
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 147
Does factor V Asp79His (409 G/C) polymorphism influence factor V and APC resistance levels? 146
Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma 143
Factor V gene mutations (R2 gene) are associated with coronary artery disease inelderly people 141
Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism 141
Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia 139
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome 137
New coagulation factor V gene polymorphisms define a single and infrequent haplotype underlying the factor V leiden mutation in Mediterranean populations and Indians 136
Modulation of factor V levels in plasma by polymorphisms in the C2 domain 134
Risks factors for highly unstable response to oral anticoagulation: a case-control study 132
Venous thromboembolism in young women - Role of thrombophilic mutations and oral contraceptive use 130
Factor V markers for the detection of genetic components of APC resistance in venous thrombosis 130
Cis-segregation of c.1171c>t stop codon (p.r391*) in serpinc1 gene and c.1691g>a transition (p.r506q) in f5 gene and selected gwas multilocus approach in inherited thrombophilia 130
Resistance to activated protein C, associated with oral contraceptives use; effect of formulations, duration of assumption, and doses of oestro- progestins 126
Novel phenotype and gamma-glutamyl carboxylase mutations in combined deficiency of vitamin K-dependent coagulation factors 126
Resistance to activated protein C in healthy women taking oral contraceptives 120
Hemostasis gene expression of the internal jugular and saphenous veins 119
Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V Leiden) and His1299 Arg substitutions in factor V 117
The Asialoglycoprotein Receptor Minor Subunit Gene Contributes to Pharmacokinetics of Factor VIII Concentrates in Hemophilia A 117
Factor V Levels in a Cohort of Patients Eligible for Oral Anticoagulant Therapy. 116
Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation 115
Factor V markers for the detection of genetic components of APC resi stance in venous thrombosis. 113
Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation. 113
Phenotype and genotype expression in pseudohomozygous factor V-LEIDEN - The need for phenotype analysis 112
Functional genetics 112
CMR+ Factor V deficiency Arg2080Cys: A model to investigate altered C2 domain-membrane interaction. 112
Increased Susceptibility to Proteases in Type 2A von Willebrand Disease Associated with two Novel Mutations (Val 867 Glu, Pro 864 His). 106
Molecular bases of pseudo-homozygous APC resistance: The compound heterozygosity for FV R506Q and a FV null mutation results in the exclusive presence of FV Leiden molecules in plasma 104
Contribution of asialoglycoprotein receptor ASGR2 5’ UTR polymorphisms to full-length FVIII concentrate pharmacokinetics 102
Polimorfismi funzionali e terapia anticoagulante 95
null 95
Severe bleeding and absent ADP-induced platelet aggregation associated with inherited combined CalDAG-GEFI and P2Y12 deficiencies 94
Combination of Genomic and Transcriptomic Approaches Highlights Vascular and Circadian Clock Components in Multiple Sclerosis 91
F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes 91
Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease 90
The asymptomatic carriership of thrombophilic defects is associated with frequent genotypes of the fibrinogen gene cluster. 89
null 88
Functional polymorphisms in the LDLR and pharmacokinetics of Factor VIII concentrates 87
Combination of CLEC4M rs868875 G-Carriership and ABO O Genotypes May Predict Faster Decay of FVIII Infused in Hemophilia A Patients 87
Expression and characterization of a factor V mutation (E1608K) detected in familial thrombophilia. 86
In vivo modulation of a dominant-negative variant in mouse models of von Willebrand disease type 2A 86
Contribution of low density lipoprotein receptor-related protein genotypes to coagulation factor VIII levels in thrombotic women 85
Lesioni molecolari ricorrenti sono responsabili di difetti funzionali del fattore VII. 79
Detection of New Polymorphic Markers in the Factor V Gene. 78
Evaluation of FV mRNA to define the residual FV expression levels in severe FV deficiency 76
Studio di mutazioni in geni dell’emostasi. 76
The asialoglycoprotein receptor ASGR2 5’ UTR polymorphisms influence several parameters of full-length FVIII concentrate pharmacokinetics 75
Studio di Mutazioni in Geni dell'Emostasi. 73
Whole-Exome Sequencing in a Family with an Unexplained Tendency for Venous Thromboembolism: Multicomponent Prediction of Low-Frequency Variant Deleteriousness and of Individual Protein Interaction 70
The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms 69
null 63
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 55
Modulation of factor VIII pharmacokinetics by genetic components in factor VIII receptors 48
Association of membranous nephropathy with familial resistance to activated protein C 46
Influence of low-density lipoprotein (LDL) receptor-related protein and ABO blood group genotypes on factor XI levels. 45
Factor V Kuwait alias factor V R3: A rare polymorphism of uncertain functional significance 43
Genetic components in factor VIII receptors for individual and genotype-modeled hemophilia A treatment 23
Reduced inhibition of activated prothrombin by heparin and venous thromboembolism: heparin resistance revisited 14
Selected cell receptor genotypes differentially modulate the ABO blood group influence on Factor VIII levels in severe aortic stenosis 13
Totale 11.371
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.297
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.297
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021676 0 0 0 0 0 100 91 116 41 138 134 56
2021/2022903 96 87 47 71 50 18 54 47 21 59 83 270
2022/2023902 93 78 24 109 130 130 67 76 100 15 46 34
2023/2024563 34 39 18 20 36 183 9 26 17 7 13 161
2024/20251.870 44 31 172 66 243 169 46 77 316 219 275 212
2025/20262.845 524 222 523 704 758 114 0 0 0 0 0 0
Totale 11.371